文献速递细菌感染、耐药与抗菌药物医院感染防控

智利耐抗菌药物细菌肠道定植高负担:社区与医院抗菌药物耐药性(ARCH)研究

High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
PubMed 文献 · Clin Infect Dis · 2023-01-01

该研究在2019冠状病毒病大流行前,于2018年12月至2019年5月在智利4所公立医院及中部社区招募住院成人和社区居住成人,检测粪便中耐抗菌药物革兰阴性杆菌(GNB)定植情况。住院者中氟喹诺酮耐药、超广谱头孢菌素耐药、碳青霉烯耐药或多重耐药GNB定植率分别为46.4%、41.2%、14.5%和26.3%,社区分别为39.5%、28.9%、5.6%和4.8%。作者认为社区是抗菌药物耐药的重要来源。

要点

  • 住院成人耐氟喹诺酮GNB定植率为46.4%(95%CI 42.9-50.0)。
  • 社区居住成人耐氟喹诺酮GNB定植率为39.5%(95%CI 34.4-44.6)。
  • 住院成人多重耐药GNB定植率为26.3%(95%CI 23.2-29.4),社区为4.8%(95%CI 2.6-7.0)。

核心结论

  • 在该住院和社区居住成人样本中观察到耐抗菌药物GNB定植高负担,提示社区是抗菌药物耐药的相关来源。
  • 需要努力了解社区和医院中传播的耐药菌株之间的相关性。

研究设计与样本

  • 2018年12月至2019年5月,在智利4所公立医院招募住院成人,并从智利中部招募社区居住者。
  • 共纳入775名住院成人和357名社区居住者,提供粪便标本和流行病学信息。
  • 标本接种于含环丙沙星或头孢他啶的麦康凯琼脂,回收的所有形态型均进行鉴定和表征。

主要发现

  • 住院者中氟喹诺酮耐药、超广谱头孢菌素耐药、碳青霉烯耐药或多重耐药GNB定植率分别为46.4%(95%CI 42.9-50.0)、41.2%(95%CI 37.7-44.6)、14.5%(95%CI 12.0-16.9)和26.3%(95%CI 23.2-29.4)。
  • 社区居住者中氟喹诺酮耐药、超广谱头孢菌素耐药、碳青霉烯耐药和多药耐药GNB定植率分别为39.5%(95%CI 34.4-44.6)、28.9%(95%CI 24.2-33.6)、5.6%(95%CI 3.2-8.0)和4.8%(95%CI 2.6-7.0)。

关键数值与推荐

  • 氟喹诺酮耐药、超广谱头孢菌素耐药、碳青霉烯耐药或多重耐药GNB按美国疾病控制与预防中心标准定义,各类别不互斥。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance is a global threat, heavily impacting low- and middle-income countries. This study estimated antimicrobial-resistant gram-negative bacteria (GNB) fecal colonization prevalence in hospitalized and community-dwelling adults in Chile before the coronavirus disease 2019 pandemic. METHODS: From December 2018 to May 2019, we enrolled hospitalized adults in 4 public hospitals and community dwellers from central Chile, who provided fecal specimens and epidemiological information. Samples were plated onto MacConkey agar with ciprofloxacin or ceftazidime added. All recovered morphotypes were identified and characterized according to the following phenotypes: fluoroquinolone-resistant (FQR), extended-spectrum cephalosporin-resistant (ESCR), carbapenem-resistant (CR), or multidrug-resistant (MDR; as per Centers for Disease Control and Prevention criteria) GNB. Categories were not mutually exclusive. RESULTS: A total of 775 hospitalized adults and 357 community dwellers were enrolled. Among hospitalized subjects, the prevalence of colonization with FQR, ESCR, CR, or MDR-GNB was 46.4% (95% confidence interval [CI], 42.9-50.0), 41.2% (95% CI, 37.7-44.6), 14.5% (95% CI, 12.0-16.9), and 26.3% (95% CI, 23.2-29.4). In the community, the prevalence of FQR, ESCR, CR, and MDR-GNB colonization was 39.5% (95% CI, 34.4-44.6), 28.9% (95% CI, 24.2-33.6), 5.6% (95% CI, 3.2-8.0), and 4.8% (95% CI, 2.6-7.0), respectively. CONCLUSIONS: A high burden of antimicrobial-resistant GNB colonization was observed in this sample of hospitalized and community-dwelling adults, suggesting that the community is a relevant source of antibiotic resistance. Efforts are needed to understand the relatedness between resistant strains circulating in the community and hospitals.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Araos R, Smith RM, Styczynski A, et al. High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clin Infect Dis. 2023. PMID: 37406045. doi:10.1093/cid/ciad283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。